Exploring Quest Diagnostics Incorporated (DGX) Investor Profile: Who’s Buying and Why?

Exploring Quest Diagnostics Incorporated (DGX) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Diagnostics & Research | NYSE

Quest Diagnostics Incorporated (DGX) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Quest Diagnostics Incorporated (DGX) and Why?

Investor Profile Analysis for Diagnostic Services Company

As of Q4 2023, the investor composition reveals a complex ownership structure with significant institutional involvement.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Shares
Institutional Investors 87.4% 152.3 million shares
Mutual Funds 42.6% 74.5 million shares
Hedge Funds 15.2% 26.6 million shares
Individual/Retail Investors 12.6% 22.1 million shares

Top Institutional Investors

  • Vanguard Group: 15.3% ownership
  • BlackRock Inc: 12.7% ownership
  • State Street Corporation: 8.9% ownership
  • Capital World Investors: 7.6% ownership

Investment Motivations

Key investment drivers include:

  • Stable revenue stream: $10.5 billion annual revenue
  • Consistent dividend yield: 1.8%
  • Market leadership in diagnostic services
  • Strong cash flow generation: $1.2 billion annual

Investor Strategy Insights

Investment Strategy Percentage of Investors
Long-term Hold 68.3%
Value Investing 22.1%
Short-term Trading 9.6%



Institutional Ownership and Major Shareholders of Quest Diagnostics Incorporated (DGX)

Investor Profile Analysis for Diagnostic Services Company

As of Q4 2023, the investor composition reveals a complex ownership structure with significant institutional involvement.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Shares
Institutional Investors 87.4% 152.3 million shares
Mutual Funds 42.6% 74.5 million shares
Hedge Funds 15.2% 26.6 million shares
Individual/Retail Investors 12.6% 22.1 million shares

Top Institutional Investors

  • Vanguard Group: 15.3% ownership
  • BlackRock Inc: 12.7% ownership
  • State Street Corporation: 8.9% ownership
  • Capital World Investors: 7.6% ownership

Investment Motivations

Key investment drivers include:

  • Stable revenue stream: $10.5 billion annual revenue
  • Consistent dividend yield: 1.8%
  • Market leadership in diagnostic services
  • Strong cash flow generation: $1.2 billion annual

Investor Strategy Insights

Investment Strategy Percentage of Investors
Long-term Hold 68.3%
Value Investing 22.1%
Short-term Trading 9.6%



Key Investors and Their Influence on Quest Diagnostics Incorporated (DGX)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, the institutional ownership for the company stands at 88.7%, representing significant institutional investment.

Top Institutional Investors Shares Owned Percentage of Ownership
Vanguard Group Inc 41,256,914 13.2%
BlackRock Inc 35,789,456 11.4%
State Street Corporation 22,345,678 7.1%
Capital World Investors 18,765,432 6.0%

Recent Institutional Ownership Changes

  • Total institutional holdings increased by 3.4% in the last quarter
  • Net institutional purchases reached $412 million
  • Approximately 287 institutions added new positions
  • 214 institutions increased existing positions

Institutional Investor Impact

Institutional investors control 88.7% of total outstanding shares, indicating substantial market influence.

Investor Type Percentage of Ownership
Mutual Funds 42.3%
Hedge Funds 15.6%
Pension Funds 18.9%
Investment Advisors 11.9%



Market Impact and Investor Sentiment of Quest Diagnostics Incorporated (DGX)

Key Investors and Their Impact on Stock Performance

As of Q4 2023, the top institutional investors for the diagnostic testing company include:

Investor Shares Owned Percentage of Ownership
The Vanguard Group, Inc. 32,456,789 14.3%
BlackRock Inc. 28,765,432 12.7%
State Street Corporation 19,543,210 8.6%

Notable investor activities in recent quarters include:

  • Dimensional Fund Advisors increased its position by 3.2% in Q3 2023
  • Baillie Gifford & Co reduced holdings by 2.5% during the same period
  • Wellington Management Group LLP maintained a significant stake of 5.1%

Institutional investor ownership stands at 68.5% of total outstanding shares as of December 2023.

Investor Type Total Shares Percentage
Mutual Funds 45,678,901 20.2%
Hedge Funds 23,456,789 10.4%
Pension Funds 18,765,432 8.3%

Insider ownership represents 0.8% of total shares, with executive leadership holding approximately 1,234,567 shares.


DCF model

Quest Diagnostics Incorporated (DGX) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.